On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Oncodesign SA's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€145k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- OVER-MYRPartner
Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance
FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗
€145ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Institut National de la Sante et de la Recherche MedicaleFrance · 1 shared project
- Vrije Universiteit BrusselBelgium · 1 shared project
- University of SouthamptonUnited Kingdom · 1 shared project
- Universitatsklinikum HeidelbergGermany · 1 shared project
- Academisch Medisch Centrum Bij de Universiteit van AmsterdamNetherlands · 1 shared project
- Inserm Transfert SAFrance · 1 shared project
- Universita Degli Studi di Bari Aldo MoroItaly · 1 shared project
- Cellzome AGGermany · 1 shared project
- The Garvan Institute of Medical Research Charitable InstitutionAustralia · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- drug resistance
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗